ASX - By Stock
|
TD1 |
Re:
FDA, CE, TGA - all regulations cleared
|
|
Southoz
|
136 |
85K |
1 |
12/11/19 |
12/11/19 |
ASX - By Stock
|
136
|
85K
|
1
|
|
ASX - By Stock
|
TD1 |
Re:
FDA, CE, TGA - all regulations cleared
|
|
Southoz
|
136 |
85K |
1 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
136
|
85K
|
1
|
|
ASX - By Stock
|
TD1 |
Re:
FDA, CE, TGA - all regulations cleared
|
|
Southoz
|
136 |
85K |
2 |
10/11/19 |
10/11/19 |
ASX - By Stock
|
136
|
85K
|
2
|
|
ASX - By Stock
|
TD1 |
Re:
FDA, CE, TGA - all regulations cleared
|
|
Southoz
|
136 |
85K |
14 |
10/11/19 |
10/11/19 |
ASX - By Stock
|
136
|
85K
|
14
|
|
ASX - By Stock
|
BOT |
Re:
What's the vehicle anyhow?
|
|
Southoz
|
161 |
65K |
35 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
161
|
65K
|
35
|
|
ASX - By Stock
|
BOT |
Re:
Look at the standard error
|
|
Southoz
|
142 |
76K |
8 |
27/10/19 |
27/10/19 |
ASX - By Stock
|
142
|
76K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Look at the standard error
|
|
Southoz
|
142 |
76K |
0 |
27/10/19 |
27/10/19 |
ASX - By Stock
|
142
|
76K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
The GREENFUND - we're buying the dip, big time, and here's why.
|
|
Southoz
|
159 |
87K |
2 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
159
|
87K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
The GREENFUND - we're buying the dip, big time, and here's why.
|
|
Southoz
|
159 |
87K |
15 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
159
|
87K
|
15
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 Acne Phase 2 Study Results Presentation
|
|
Southoz
|
650 |
327K |
6 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
650
|
327K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 Acne Phase 2 Study Results Presentation
|
|
Southoz
|
650 |
327K |
7 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
650
|
327K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 Acne Phase 2 Study Results Presentation
|
|
Southoz
|
650 |
327K |
6 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
650
|
327K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 Acne Phase 2 Study Results Presentation
|
|
Southoz
|
650 |
327K |
13 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
650
|
327K
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3
|
|
Southoz
|
402 |
243K |
11 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
402
|
243K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Why are the trials so slow?
|
|
Southoz
|
9 |
3.8K |
4 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
9
|
3.8K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Season 15 Episode 1
|
|
Southoz
|
17 |
5.7K |
14 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
17
|
5.7K
|
14
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ArTiMist Appeal Reasons For Decision
|
|
Southoz
|
102 |
22K |
9 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
102
|
22K
|
9
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ArTiMist Appeal Reasons For Decision
|
|
Southoz
|
102 |
22K |
13 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
102
|
22K
|
13
|
|
ASX - By Stock
|
ALA |
Re:
Paul Hopper
|
|
Southoz
|
15 |
7.0K |
5 |
02/10/19 |
02/10/19 |
ASX - By Stock
|
15
|
7.0K
|
5
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ArTiMist Appeal Lodged With TGA
|
|
Southoz
|
185 |
120K |
10 |
14/08/19 |
14/08/19 |
ASX - By Stock
|
185
|
120K
|
10
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ZolpiMist Clinical Results Published
|
|
Southoz
|
44 |
27K |
4 |
10/08/19 |
10/08/19 |
ASX - By Stock
|
44
|
27K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ZolpiMist Clinical Results Published
|
|
Southoz
|
44 |
27K |
5 |
10/08/19 |
10/08/19 |
ASX - By Stock
|
44
|
27K
|
5
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ZolpiMist Clinical Results Published
|
|
Southoz
|
44 |
27K |
18 |
10/08/19 |
10/08/19 |
ASX - By Stock
|
44
|
27K
|
18
|
|
ASX - By Stock
|
ALA |
Re:
Someone should tell Steve.....
|
|
Southoz
|
11 |
5.7K |
11 |
01/08/19 |
01/08/19 |
ASX - By Stock
|
11
|
5.7K
|
11
|
|
ASX - By Stock
|
ALA |
Re:
Someone should tell Steve.....
|
|
Southoz
|
11 |
5.7K |
19 |
01/08/19 |
01/08/19 |
ASX - By Stock
|
11
|
5.7K
|
19
|
|
ASX - By Stock
|
BIT |
Re:
Statistical issues in the analysis of BITs P2 trial
|
|
Southoz
|
27 |
12K |
18 |
17/07/19 |
17/07/19 |
ASX - By Stock
|
27
|
12K
|
18
|
|
ASX - By Stock
|
BIT |
Re:
Statistical issues in the analysis of BITs P2 trial
|
|
Southoz
|
27 |
12K |
16 |
16/07/19 |
16/07/19 |
ASX - By Stock
|
27
|
12K
|
16
|
|
ASX - By Stock
|
BIT |
Re:
Statistical issues in the analysis of BITs P2 trial
|
|
Southoz
|
27 |
12K |
20 |
15/07/19 |
15/07/19 |
ASX - By Stock
|
27
|
12K
|
20
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
Southoz
|
604 |
198K |
8 |
14/07/19 |
14/07/19 |
ASX - By Stock
|
604
|
198K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
Southoz
|
604 |
198K |
13 |
12/07/19 |
12/07/19 |
ASX - By Stock
|
604
|
198K
|
13
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL Parkinsons trial patient data 2 years after implant
|
|
Southoz
|
65 |
24K |
3 |
17/05/19 |
17/05/19 |
ASX - By Stock
|
65
|
24K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Southoz
|
194 |
101K |
5 |
15/05/19 |
15/05/19 |
ASX - By Stock
|
194
|
101K
|
5
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL Parkinsons trial patient data 2 years after implant
|
|
Southoz
|
65 |
24K |
5 |
15/05/19 |
15/05/19 |
ASX - By Stock
|
65
|
24K
|
5
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL Parkinsons trial patient data 2 years after implant
|
|
Southoz
|
65 |
24K |
6 |
13/05/19 |
13/05/19 |
ASX - By Stock
|
65
|
24K
|
6
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ArTiMist Regulatory Update
|
|
Southoz
|
141 |
40K |
2 |
23/04/19 |
23/04/19 |
ASX - By Stock
|
141
|
40K
|
2
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ArTiMist Regulatory Update
|
|
Southoz
|
141 |
40K |
4 |
22/04/19 |
22/04/19 |
ASX - By Stock
|
141
|
40K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ArTiMist Regulatory Update
|
|
Southoz
|
141 |
40K |
10 |
21/04/19 |
21/04/19 |
ASX - By Stock
|
141
|
40K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Submits De Novo Application to the FDA
|
|
Southoz
|
107 |
64K |
4 |
17/04/19 |
17/04/19 |
ASX - By Stock
|
107
|
64K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Program Update Anagrelide
|
|
Southoz
|
94 |
42K |
7 |
16/03/19 |
16/03/19 |
ASX - By Stock
|
94
|
42K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Cancer Vaccine Study Results
|
|
Southoz
|
247 |
97K |
4 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
247
|
97K
|
4
|
|
Political Debate
|
|
Re:
Hiistoric loss by govt on floor of the House
|
|
Southoz
|
69 |
15K |
5 |
12/02/19 |
12/02/19 |
Political Debate
|
69
|
15K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
A new Beginning...
|
|
Southoz
|
3.4K |
1.9M |
9 |
08/02/19 |
08/02/19 |
ASX - By Stock
|
3.4K
|
1.9M
|
9
|
|
ASX - By Stock
|
RAP |
Re:
A new Beginning...
|
|
Southoz
|
3.4K |
1.9M |
4 |
04/02/19 |
04/02/19 |
ASX - By Stock
|
3.4K
|
1.9M
|
4
|
|
ASX - By Stock
|
RAP |
Re:
A new Beginning...
|
|
Southoz
|
3.4K |
1.9M |
9 |
04/02/19 |
04/02/19 |
ASX - By Stock
|
3.4K
|
1.9M
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Let's move on
|
|
Southoz
|
124 |
49K |
8 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
124
|
49K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment
|
|
Southoz
|
52 |
19K |
1 |
07/01/19 |
07/01/19 |
ASX - By Stock
|
52
|
19K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment
|
|
Southoz
|
52 |
19K |
3 |
07/01/19 |
07/01/19 |
ASX - By Stock
|
52
|
19K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US FDA requests further data for VivaGel BV approval
|
|
Southoz
|
158 |
77K |
17 |
01/01/19 |
01/01/19 |
ASX - By Stock
|
158
|
77K
|
17
|
|
ASX - By Stock
|
BIT |
Re:
Commentary on the BIT Phase 2 Trial Data
|
|
Southoz
|
336 |
144K |
42 |
09/12/18 |
09/12/18 |
ASX - By Stock
|
336
|
144K
|
42
|
|
ASX - By Stock
|
BIT |
Re:
HIV Wonder Drug BIT225
|
|
Southoz
|
730 |
307K |
9 |
01/12/18 |
01/12/18 |
ASX - By Stock
|
730
|
307K
|
9
|
|